Selinexor in Combination with Salvage Regimen for Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients with TP53 Alterations

被引:1
|
作者
Wang, Li [1 ,2 ]
Fang, Ying [1 ]
Zhang, Muchen [1 ]
Xiong, Jie [1 ]
Xu, Pengpeng [1 ]
Chen, Shu [1 ]
Zhao, Weili [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, Sch Med,Rui Jin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, Shanghai, Shanghai, Peoples R China
[2] Chinese French Res Ctr Living Sci & Genom, Lab Mol Pathol, Shanghai, Peoples R China
关键词
D O I
10.1182/blood-2023-182674
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Selinexor in Combination with R-GDP/R-ICE Regimen for Refractory Aggressive Large B-Cell Lymphoma Patients with TP53 Alterations
    Wang, Li
    Liu, Mengke
    Fang, Ying
    Zhang, Muchen
    Xiong, Jie
    Cheng, Lili
    Zhao, Weili
    [J]. BLOOD, 2022, 140 : 9542 - 9543
  • [2] TP53 dysfunction in diffuse large B-cell lymphoma
    Lu, Ting-Xun
    Young, Ken H.
    Xu, Wei
    Li, Jian-Yong
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 97 : 47 - 55
  • [3] Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
    Voropaeva, Elena N.
    Pospelova, Tatyana I.
    Voevoda, Mikhail I.
    Maksimov, Vladimir N.
    Orlov, Yuriy L.
    Seregina, Olga B.
    [J]. BMC MEDICAL GENOMICS, 2019, 12 (Suppl 2)
  • [4] Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
    Elena N. Voropaeva
    Tatyana I. Pospelova
    Mikhail I. Voevoda
    Vladimir N. Maksimov
    Yuriy L. Orlov
    Olga B. Seregina
    [J]. BMC Medical Genomics, 12
  • [5] Frequency, Spectrum, and Functional Significance of TP53 Mutations in Patients with Diffuse Large B-Cell Lymphoma
    Voropaeva, E. N.
    Pospelova, T. I.
    Voevoda, M. I.
    Maksimov, V. N.
    [J]. MOLECULAR BIOLOGY, 2017, 51 (01) : 53 - 60
  • [6] Frequency, spectrum, and functional significance of TP53 mutations in patients with diffuse large B-cell lymphoma
    E. N. Voropaeva
    T. I. Pospelova
    M. I. Voevoda
    V. N. Maksimov
    [J]. Molecular Biology, 2017, 51 : 53 - 60
  • [7] A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Kalakonda, Nagesh
    Cavallo, Federica
    Follows, George
    Goy, Andre
    Vermaat, Joost S. P.
    Casasnovas, Olivier
    Lavee, Orly
    Maerevoet, Marie
    Zijlstra, Josee
    Bakhshi, Sameer
    Bouabdallah, Reda
    Choquet, Sylvain
    Gurion, Ronit
    Hill, Brian
    Jaeger, Ulrich
    Sancho, Juan-Manuel
    Schuster, Michael
    Thieblemont, Catherine
    De la Cruz, Fatima
    Egyed, Miklos
    Mishra, Sourav
    Offner, Fritz
    Vassilakopoulos, Theodoros
    Warzocha, Krzysztof
    McCarthy, Daniel
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita
    Shah, Jatin
    Van den Neste, Eric
    Canales, Miguel
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S248 - S249
  • [8] A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma
    A J Davies
    A M Lee
    C Taylor
    A J Clear
    L K Goff
    S Iqbal
    D Cuthbert-Heavens
    M Calaminici
    A J Norton
    T A Lister
    J Fitzgibbon
    [J]. Leukemia, 2005, 19 : 1459 - 1465
  • [9] A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma
    Davies, AJ
    Lee, AM
    Taylor, C
    Clear, AJ
    Goff, LK
    Iqbal, S
    Cuthbert-Heavens, D
    Calaminici, M
    Norton, AJ
    Lister, TA
    Fitzgibbon, J
    [J]. LEUKEMIA, 2005, 19 (08) : 1459 - 1465
  • [10] Triple Haplotypes of the TP53 Gene in Patients with Diffuse Small B-Cell Lymphoma
    E. N. Voropaeva
    N. V. Cherdyntseva
    M. I. Voevoda
    T. I. Pospelova
    V. N. Maximov
    Yu. L. Orlov
    T. A. Ageeva
    [J]. Russian Journal of Genetics, 2019, 55 : 1564 - 1568